Placebo to Guselkumab Solution for injection in pre-filled syringe 100 mg/ml., Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL
CNTO1959PSA3004
Phase 3 small_molecule active
Quick answer
Placebo to Guselkumab Solution for injection in pre-filled syringe 100 mg/ml., Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL for Psoriatic arthritis (PsA) is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Psoriatic arthritis (PsA)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active